Evidence map›Paper›PMID 19775242›Full record

ArticleThe Biochemical journal2009

Post-translational modifications of connexin26 revealed by mass spectrometry.

Darren Locke, Shengjie Bian, Hong Li, Andrew L Harris

Abstract read
In one paragraph

Article in The Biochemical journal, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 64 citations in OpenAlex.

  1. Deceiving the gatekeepers: virus modulation of gap junctions.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Mechanisms of Connexin Regulating Peptides.International journal of molecular sciences · 2021
    Review
  8. Review
  9. Review
  10. Electrical coupling and its channels.The Journal of general physiology · 2018
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. The role of post-translational modifications in hearing and deafness.Cellular and molecular life sciences : CMLS · 2016
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Darren LockeDepartment of Pharmacology and Physiology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ 07103, USA. lockeda@umdnj.edu
Shengjie Bian
Hong Li
Andrew L Harris
Rutgers, The State University of New Jersey · USUniversity Hospital, Newark · US

Funding

Rutgers Mass Spectrometry Core for Integrative Neuroscience ResearchP30NS046593 · NINDS · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI LI, HONG, LOBEL, PETER · 2004 to 2018
$9.9M
PHYSIOLOGY OF RECONSTITUTED GAP JUNCTION CHANNELSR01GM036044 · NIGMS · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI HARRIS, ANDREW L · 1986 to 2007
$1.4M
STRUCTURE-FUNCTION OF CONNEXIN PORESR01NS056509 · NINDS · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI HARRIS, ANDREW L · 2006 to 2009
$1.4M
PROPERTIES OF CONNEXIN CHANNELS THAT CAUSE DEAFNESSR21DC007470 · NIDCD · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI HARRIS, ANDREW L · 2005 to 2006
$414k
NIDCD NIH HHS DC7470NIDCD NIH HHS R21 DC007470NIGMS NIH HHS GM36044NIGMS NIH HHS R01 GM036044NINDS NIH HHS NS046593NINDS NIH HHS NS56509NINDS NIH HHS P30 NS046593NINDS NIH HHS R01 NS056509
6 · The paper itself

Abstract

Gap junctions play important roles in auditory function and skin biology; mutations in the Cx26 (connexin26) gene are the predominant cause of inherited non-syndromic deafness and cause disfiguring skin disorders. Mass spectrometry (MS) was used to identify PTMs (post-translational modifications) of Cx26 and to determine whether they occur at sites of disease-causing mutations. Cx26 was isolated from transfected HeLa cells by sequential immunoaffinity and metal chelate chromatography using a tandem C-terminal haemagglutinin epitope and a (His-Asn)6 sequence. In-gel and in-solution enzymatic digestions were carried out in parallel with trypsin, chymotrypsin and endoproteinase GluC. Peptides were fractionated using a reversed-phase matrix by stepwise elution with increasing concentrations of organic solvent. To improve detection of low-abundance peptides and to maximize sequence coverage, MALDI-TOF-MS (matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry; MS) and MALDI-TOF/TOF-MS/MS (matrix-assisted laser desorption/ionization-time-of-flight/time-of-flight tandem mass spectrometry; MS/MS) spectra were acquired from each elution step using an Applied Biosystems 4800 tandem mass spectrometer. Acquisition, processing and interpretation parameters were optimized to improve ionization and fragmentation of hydrophobic peptides. MS and MS/MS coverage of Cx26 was significantly above that reported for other membrane proteins: 71.3% by MS, with 29.9% by MS/MS. MS coverage was 92.6% if peptides resulting from in-source collisions and/or partial enzymatic cleavages were considered. A variety of putative PTMs of Cx26 were identified, including acetylation, hydroxylation, gamma-carboxyglutamation, methylation and phosphorylation, some of which are at sites of deafness-causing mutations. Knowledge of the PTMs of Cx26 will be instrumental in understanding how alterations in the cellular mechanisms of Cx26 channel biogenesis and function lead to losses in auditory function and disfiguring skin disorders.

Indexed as

Protein Processing, Post-Translational1-Carboxyglutamic AcidAcetylationAmino Acid SequenceAnimalsBlotting, WesternChymotrypsinConnexin 26ConnexinsDeafnessEndopeptidasesHeLa CellsHumansHydroxylationMass SpectrometryMethylation1-Carboxyglutamic AcidChymotrypsinConnexin 26ConnexinsEndopeptidasesGJB2 protein, humanGjb2 protein, ratPeptide FragmentsTrypsin

Identifiers

PMID19775242
PMCPMC4640697
OpenAlexW2147318619

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.